23rd Oct 2025 Plain language summary of the IMerge Phase 3 study: imetelstat vs placebo in lower-risk myelodysplastic syndrome patients with anemia
26th Jun 2024 PEGASUS study: A plain language summary looking treatment of paroxysmal nocturnal hemoglobinuria with pegcetacoplan for 48 weeks
20th Nov 2023 A plain language summary comparing pegcetacoplan with supportive care for 26 weeks in participants with paroxysmal nocturnal hemoglobinuria
25th Jul 2023 Plain Language Summary: the PEGASUS study comparing pegcetacoplan with eculizumab for 16 weeks in people with paroxysmal nocturnal hemoglobinuria
